International Trade Commission Briefing 2026-03-04
Estimated reading time: 5 minutes
1. Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
Sub: International Trade Commission
Content: Notice is hereby given that the U.S. International Trade Commission has received a complaint entitled Certain Pertuzumab Biosimilars, Including Those Made by Certain Methods of Manufacturing, the Active Ingredient Thereof, and Products Containing the Same, DN 3890; the Commission is soliciting comments on any public interest issues raised by the complaint or complainant's filing pursuant to the Commission's Rules of Practice and Procedure.
2. Certain Magnetoresistive Random Access Memory (MRAM) Devices, Products Containing Same and Components Thereof; Notice of Institution of Investigation
Sub: International Trade Commission
Content: Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on January 28, 2026, under section 337 of the Tariff Act of 1930, as amended, on behalf of Avalanche Technology, Inc. of Fremont, California. An amended complaint was filed on February 5, 2026. The amended complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain magnetoresistive random access memory (MRAM) devices, products containing same and components thereof by reason of the infringement of certain claims of U.S. Patent No. 9,318,179 ("the '179 patent"); U.S. Patent No. 9,419,210 ("the '210 patent"); U.S. Patent No. 11,678,586 ("the '586 patent"); and U.S. Patent No. 10,490,737 ("the '737 patent"). The amended complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and a cease and desist order.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
